抗流感板块大幅调整，海南海药触及跌停，金迪克、嘉应制药、华兰疫苗、亚太药业、康芝药业、联环 药业等跟跌。 ...

Group 1 - The core point of the article is the successful passing of the proposal to amend the company's articles of association during the fifth extraordinary general meeting of shareholders held on November 18, 2025, with a high approval rate of 98.76% overall and 70.03% among minority shareholders [1][4]. Group 2 - The meeting was held at 14:30 on November 18, 2025, in Haikou, Hainan Province, with both on-site and online voting options available [2]. - A total of 491 shareholders participated in the voting, representing 417,968,270 shares, which is 32.2167% of the company's total share capital [3]. - The voting results for the amendment proposal showed that 412,780,208 shares were in favor, accounting for 98.7587% of the votes cast, while 4,887,062 shares were against, and 301,000 shares were abstained [4]. Group 3 - The legal opinion provided by Beijing Dacheng (Haikou) Law Firm confirmed that the meeting's procedures, attendance, and voting results complied with relevant laws and regulations, deeming the resolutions valid [5].

海南海药股份有限公司 章程 （经 2025 年 11 月 18 日公司 2025 年第五次临时股东会审议通过） 二〇二五年十一月 1 第一章 总 则 第一条 为维护公司、股东和债权人的合法权益，规范公司的组织和行为，根据《中 华人民共和国公司法》（以下简称《公司法》）、《中华人民共和国证券法》（以下简 称《证券法》）、《中国共产党章程》和其他有关规定，制订本章程。 第二条 公司系依照《股票发行与交易管理暂行条例》和国家体改委《股份有限公 司规范意见》、《海南经济特区股份有限公司条例》等有关规定成立的股份有限公司（以 下简称"公司"）。 公司经海南省股份制试点领导小组办公室（琼股办字[1992]10 号文）批准，以定向 募集方式设立；在海南省市场监督管理局注册登记，取得营业执照。统一社会信用代码： 91460000201289453D。 《公司法》实施后，公司已按照有关规定对照《公司法》进行了规范并依法履行了 重新登记手续。 第三条 公司于 1993 年 12 月 29 日经中国证券监督管理委员会（证监发字[1993]115 号文）批准，首次向社会公众发行人民币普通股 A 股 2500 万股，于 1994 年 ...

北京大成（海口）律师事务所 关于海南海药股份有限公司2025年第五次临时股东大会的 法 律 意 见 书 大成 is Dentons' Preferred Law Firm in China. 本法律意见书仅供见证公司本次股东大会相关事项的合法性之目的使用，不 得用作任何其他目的。 本所及经办律师依据《证券法》《律师事务所从事证券法律业务管理办法》 和《律师事务所证券法律业务执业规则（试行）》等规定及本法律意见书出具日 以前已经发生或者存在的事实，严格履行了法定职责，遵循了勤勉尽责和诚实信 用原则，进行了充分的核查验证，保证本法律意见所认定的事实真实、准确、完 整，所发表的结论性意见合法、准确，不存在虚假记载、误导性陈述或者重大遗 漏，并承担相应法律责任。 本所律师根据《股东会规则》第六条的要求，按照律师行业公认的业务标准、 道德规范和勤勉尽责的精神，对本次股东大会所涉及的有关事项和相关文件进行 了必要的核查和验证，出席了本次股东大会，出具法律意见如下： 一、本次股东大会的召集、召开的程序 北京大成（海口）律师事务所 北京大成（海口）律师事务所 关于海南海药股份有限公司2025年第五次临时股东大会 的法律意见书 ...

海南海药股份有限公司 2025 年第五次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 证券代码：000566 证券简称：海南海药 公告编号：2025-071 一、特别提示： 1、本次股东大会无否决议案的情形； 2、本次股东大会不涉及变更前次股东大会决议的情形。 二、会议召开的情况 1、会议召开的日期、时间： 现场会议召开时间：2025年11月18日14：30 网络投票时间：2025年11月18日 （1）通过深圳证券交易所交易系统进行网络投票的时间为：2025年11月18日 9：15～9：25，9：30～11：30和13：00～15：00； （2）通过深圳证券交易所互联网投票系统投票的时间为：2025年11月18日9:15～ 15:00期间的任意时间。 2、召开地点：海南省海口市秀英区南海大道 192 号海药工业园公司会议室 3、召开方式：采用现场表决与网络投票相结合的方式召开 4、召集人：公司第十一届董事会 5、现场会议主持人：公司第十一届董事会董事长王建平 通过现场和网络投票的中小股东 490 人，代表股份 17,308,089 股， ...

Market Overview - As of November 18, the Shanghai Composite Index closed at 3939.81 points, down 32.22 points, a decline of 0.81% [1] - The Shenzhen Component Index closed at 13080.49 points, down 121.52 points, a decline of 0.92% [1] - The ChiNext Index closed at 3069.22 points, down 35.98 points, a decline of 1.16% [1] High Turnover Stocks - A total of 100 A-shares had a turnover rate exceeding 20% on November 18, with six stocks, including Beikong Detection and C Hengkong, having turnover rates above 50% [1] - Beikong Detection (stock code: 920160) had a closing price of 26.50 yuan and a turnover rate of 88.46%, with a price increase of 295.52% [1] - C Hengkong (stock code: 688727) closed at 61.55 yuan, with a turnover rate of 81.36% and a price increase of 310.61% [1] - Other notable stocks with high turnover rates include C Nanshu (75.35% turnover, 224.78% increase) and Zhongfutong (53.96% turnover, -3.19% decrease) [1] Additional High Turnover Stocks - Other stocks with significant turnover rates include: - Xue Ren Group (50.33% turnover, -2.55% decrease) [1] - Jianglong Boat (46.42% turnover, -2.02% decrease) [1] - Xuanya International (44.73% turnover, 20.01% increase) [1] - Hongxiang Co. (44.63% turnover, 5.98% increase) [1] - The list continues with various companies showing diverse performance in terms of turnover and price changes [2][3][4]

Investment Rating - The report does not provide a specific investment rating for the industry or companies mentioned [1]. Core Insights - The report highlights several new stock listings and trading activities scheduled for November 18, 2025, including companies such as Jingchuang Electric (12.10), Beikang Testing (6.70), and Nanguang Digital (5.69) [1]. - It also mentions various corporate actions such as tender offers, cash options, and acquisition requests, indicating active market movements [1]. Summary by Relevant Sections - **New Stock Listings**: Companies like Jingchuang Electric, Beikang Testing, and Nanguang Digital are set to debut on the market with respective prices of 12.10, 6.70, and 5.69 [1]. - **Corporate Actions**: The report details several corporate actions including a tender offer for Tianpu Co. (605255) from November 20 to December 19, 2025, and cash options for Hangqi Wheel B (200771) from November 19 to November 25, 2025 [1]. - **Market Alerts**: It lists companies experiencing significant fluctuations, such as Moen Electric (002451) and Huasheng Lithium Battery (688353), indicating potential investment risks and opportunities [1].

Core Viewpoint - Hainan Haiyao's trading volume reached 2.245 billion RMB, marking the highest level since November 2, 2015, with a stock price increase of 10.07% and a turnover rate of 24.18% [2] Company Summary - Hainan Haiyao Co., Ltd. was established on December 30, 1992, with a registered capital of 1.297365126 billion RMB [2]

Core Viewpoint - The Hainan Free Trade Zone sector experienced significant fluctuations, with several stocks reaching their daily limit up, indicating strong investor interest and market activity [1] Group 1: Stock Performance - Hainan Haiyao and Haima Automobile both hit the daily limit up, showcasing robust performance in the market [1] - Kangzhi Pharmaceutical, Shennong Seed Industry, and Xinlong Holdings saw their stock prices increase by over 5%, reflecting positive market sentiment towards these companies [1]

Core Viewpoint - The stock of Hainan Haiyao Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price increase of over 20% on November 14 and 17, 2025 [2]. Group 1: Stock Trading Abnormality - The stock price fluctuation is classified as an abnormal trading situation according to the regulations of the Shenzhen Stock Exchange [2]. - The company has confirmed that there are no corrections or supplements needed for previously disclosed information [3][5]. Group 2: Company Verification - The company conducted an internal review and found no significant changes in its operational environment or business conditions [4]. - There are no undisclosed major matters related to the company that should have been disclosed according to regulations [4][5]. - During the period of stock fluctuation, neither the company nor its major shareholders engaged in buying or selling the company's stock [4].